ELAN - EVAH signs acquisition and development agreements for four technologies from Elanco
EVAH has signed four contracts with Elanco Animal Health Incorporated ([[ELAN]] -0.6%) to acquire and develop technologies in animal health (two feed additives and two vaccines) targeting three species: salmon, swine and poultry.EVAH is a biotechnology company specializing in the development of biologicals to help prevent bacterial diseases in food animals and microbiome solutions for growth performance. EVAH intends to develop the products in consultation with Elanco up to an advanced pre-commercial stage.Terms of the deal were not disclosed.
For further details see:
EVAH signs acquisition and development agreements for four technologies from Elanco